Deprenyl is a selective, irreversible (covalent) inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. References: Knoll J, Miklya I. Longevity study with low doses of selegiline/(-)-deprenyl and (2R)-1-(1-benzofuran-2-yl)-N-propylpentane-2-amine (BPAP). Life Sci. 2016 Dec 15;167:32-38. doi: 10.1016/j.lfs.2016.10.023. Epub 2016 Oct 22. PubMed PMID: 27777099.

纯度：≥98%

CAS：2323-36-6